Literature DB >> 19730251

Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury.

Soheyl Bahrami1, Linda Pelinka, Anna Khadem, Sonja Maitzen, Gerhard Hawa, Martijn van Griensven, Heinz Redl.   

Abstract

OBJECTIVES: C-type natriuretic peptide (CNP), a member of the natriuretic peptide family, is produced in vascular endothelium. We assessed the accuracy of natriuretic (NT)-proCNP, the N-terminal fragment of the C-type natriuretic peptide precursor, in predicting development of sepsis in multiple-traumatized patients with/without traumatic brain injury verified by computed tomography.
DESIGN: Retrospective clinical study.
SETTING: Level II trauma center. PATIENTS: Three patient groups were stratified according to computed tomography results: isolated traumatic brain injury (n = 20), multiple-traumatized with traumatic brain injury (n = 26) and multiple-traumatized without traumatic brain injury (n = 26). During 13 days after multiple trauma, 37 (51%) patients developed sepsis.
MEASUREMENTS AND MAIN RESULTS: Circulating plasma NT-proCNP levels were measured daily (days 0-13) in all patients. Without any retrospective stratification of trauma patients, plasma NT-proNCP levels did not differ in septic (n = 37) and nonseptic (n = 35) patients (p = .505). Between days 2 and 6 posttrauma, there was a significant (p = .002) increase of circulating NT-proCNP in multiple-traumatized patients without traumatic brain injury who developed sepsis (n = 19) compared with nonseptic multiple-traumatized patients without traumatic brain injury. Conversely, in septic patients either with traumatic brain injury alone or with multiple trauma and traumatic brain injury, the NT-proCNP showed a trend toward lower levels than in nonseptic patients. Prediction of sepsis (receiver-operating characteristic test) from days 2 to 6 after multiple trauma by NT-proCNP in patients without traumatic brain injury was accurate with an area under the curve of 0.84 +/- 0.03. The optimal cutoff value of 2.3 pmol/L produced sensitivity of 84% to 96% and specificity of 61% to 91% from day 2 to 6 after trauma.
CONCLUSIONS: Our data showed that the levels of circulating NT-proCNP between multiple-traumatized patients without traumatic brain injury who do and do not develop sepsis are distinctly different. Plasma NT-proCNP concentration can potentially serve as an accurate predictor of sepsis in this cohort of patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19730251     DOI: 10.1097/CCM.0b013e3181b78a06

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  14 in total

1.  Dynamic detection of N-terminal pro-B-type natriuretic peptide helps to predict the outcome of patients with major trauma.

Authors:  A Qian; M Zhang; G Zhao
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-03       Impact factor: 3.693

2.  Biomarkers of sepsis, a never-ending story.

Authors:  Simona Mărgărit
Journal:  Rom J Anaesth Intensive Care       Date:  2014-10

Review 3.  The pathogenesis of sepsis.

Authors:  Deborah J Stearns-Kurosawa; Marcin F Osuchowski; Catherine Valentine; Shinichiro Kurosawa; Daniel G Remick
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

4.  Concomitant assessment of PSP and NT-proCNP as predictive markers of sepsis in severe trauma patients under mechanical ventilation.

Authors:  Aurélie Gouel-Chéron; Maryline Dupin; Marine Chanteperdix; Isabelle Chaillol; Fabienne Venet; Alexandre Pachot; Guillaume Monneret; Bernard Floccard; Bernard Allaouchiche
Journal:  Crit Care       Date:  2013-05-23       Impact factor: 9.097

5.  Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis.

Authors:  Marcin F Osuchowski; Florin Craciun; Katrin M Weixelbaumer; Elizabeth R Duffy; Daniel G Remick
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

6.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

7.  Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients.

Authors:  Alexander Koch; Sebastian Voigt; Edouard Sanson; Hanna Dückers; Andreas Horn; Henning W Zimmermann; Christian Trautwein; Frank Tacke
Journal:  Crit Care       Date:  2011-01-31       Impact factor: 9.097

8.  Efficacy of Xuebijing Combined with Ulinastatin in the Treatment of Traumatic Sepsis and Effects on Inflammatory Factors and Immune Function in Patients.

Authors:  Yuanchao Su; Yunliang Zhang; Hongsheng Yuan; Chuan Shen
Journal:  Front Surg       Date:  2022-05-03

9.  The prognostic value of concomitant assessment of NT-proCNP, C-reactive protein, procalcitonin and inflammatory cytokines in septic patients.

Authors:  Ryszard Tomasiuk; Malgorzata Mikaszewska-Sokolewicz; Stanislaw Szlufik; Piotr Rzepecki; Tomasz Lazowski
Journal:  Crit Care       Date:  2014-06-25       Impact factor: 9.097

10.  Relationship between age/gender-induced survival changes and the magnitude of inflammatory activation and organ dysfunction in post-traumatic sepsis.

Authors:  Susanne Drechsler; Katrin Weixelbaumer; Pierre Raeven; Mohammad Jafarmadar; Anna Khadem; Martijn van Griensven; Soheyl Bahrami; Marcin Filip Osuchowski
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.